 |
|
Immune Status of Blood Product Recipients
Janine Jason, MD;
Margaret Hilgartner, MD;
Robert C. Holman, MS;
Gloria Dixon, RN;
Thomas J. Spira, MD;
Louis Aledort, MD;
Bruce Evatt, MD
JAMA. 1985;253(8):1140-1145.
Abstract
| |
Persons with hemophilia are at risk of the acquired immunodeficiency syndrome (AIDS), and clinically asymptomatic hemophiliacs have shown a high incidence of AIDS-like immune abnormalities, facts leading to speculation that many hemophiliacs have been exposed to the AIDS agent through their blood products. We therefore evaluated the immune status of three groups of blood product recipients without AIDS in New York City, including 47 persons with hemophilia A receiving factor VIII concentrate, 50 persons with homozygous β-thalassemia, and 27 persons with sickle cell anemia receiving frozen-packed RBCs and 20 healthy persons who had not received a transfusion. Hemophiliac participants had significantly lower lymphocyte counts (median, 1,826/cu mm) than did the thalassemic (6,110/cu mm) or anemic (4,443/cu mm) participants, had lower numbers of T-helper lymphocytes (median, 533 cells/cu mm v 1,733 cells/cu mm and 1,554 cells/cu mm), and had a lower T-helper/suppressor ratio (median, 0.8 v 1.8 and 2.1). These differences remained after adjustment for age and sex. Thus, AIDS-like immune abnormalities were found in patients receiving factor concentrate, but not in those receiving RBCs. These defects could be due to both an immunosuppressive effect of the lyophilized factor itself and to contact with the AIDS agent.
(JAMA 1985;253:1140-1145)
Author Affiliations
From the Division of Host Factors, Center for Infectious Diseases, Centers for Disease Control, Atlanta (Drs Jason, Spira, and Evatt, Mr Holman, and Ms Dixon); the Department of Pediatrics, Hemophilia Center, New York Hospital-Cornell Medical Center (Dr Hilgartner), Hematology Center, Mount Sinai Hospital (Ms Forster), and the Department of Medicine, Mount Sinai Medical School (Dr Aledort), New York; and the National Hemophilia Foundation, New York (Dr Aledort).
Footnotes
Reprints not available.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Infection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody-Positive Blood Donations
Donegan et al.
ANN INTERN MED 1990;113:733-739.
ABSTRACT
Blood Transfusion and Outcome in Stage III Head and Neck Carcinoma
Johnson et al.
Arch Otolaryngol Head Neck Surg 1987;113:307-310.
ABSTRACT
AIDS in the Transfused Patient
Hilgartner
Arch Pediatr Adolesc Med 1987;141:194-198.
ABSTRACT
Human T-Lymphotropic Retrovirus Type III / Lymphadenopathy-Associated Virus Antibody: Association With Hemophiliacs' Immune Status and Blood Component Usage
Jason et al.
JAMA 1985;253:3409-3415.
ABSTRACT
|
